Stifel Financial Corp Buys 2,664 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Stifel Financial Corp increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 4.9% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 56,838 shares of the company's stock after purchasing an additional 2,664 shares during the quarter. Stifel Financial Corp's holdings in HCA Healthcare were worth $23,117,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of HCA. Dynamic Advisor Solutions LLC lifted its holdings in HCA Healthcare by 4.7% in the second quarter. Dynamic Advisor Solutions LLC now owns 5,657 shares of the company's stock valued at $1,817,000 after acquiring an additional 252 shares during the period. Sequoia Financial Advisors LLC lifted its holdings in HCA Healthcare by 12.5% in the second quarter. Sequoia Financial Advisors LLC now owns 2,446 shares of the company's stock valued at $786,000 after acquiring an additional 272 shares during the period. Bangor Savings Bank increased its position in HCA Healthcare by 112.5% in the second quarter. Bangor Savings Bank now owns 85 shares of the company's stock worth $27,000 after buying an additional 45 shares in the last quarter. Wedmont Private Capital increased its position in HCA Healthcare by 5.3% in the second quarter. Wedmont Private Capital now owns 2,720 shares of the company's stock worth $882,000 after buying an additional 136 shares in the last quarter. Finally, Diversified Trust Co increased its position in HCA Healthcare by 1.3% in the second quarter. Diversified Trust Co now owns 43,850 shares of the company's stock worth $14,088,000 after buying an additional 562 shares in the last quarter. Institutional investors own 62.73% of the company's stock.

HCA Healthcare Trading Down 0.4 %

Shares of NYSE:HCA traded down $1.29 during trading on Monday, hitting $318.46. The company had a trading volume of 1,405,393 shares, compared to its average volume of 1,203,823. The stock has a market cap of $80.67 billion, a price-to-earnings ratio of 14.36, a price-to-earnings-growth ratio of 1.23 and a beta of 1.63. HCA Healthcare, Inc. has a one year low of $255.73 and a one year high of $417.14. The company has a fifty day simple moving average of $363.85 and a two-hundred day simple moving average of $358.89. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a yield of 0.83%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare's payout ratio is currently 11.85%.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Wolfe Research upgraded HCA Healthcare to a "strong-buy" rating in a research report on Thursday, August 29th. Oppenheimer increased their target price on HCA Healthcare from $390.00 to $400.00 and gave the stock an "outperform" rating in a research report on Monday, October 28th. Cantor Fitzgerald reiterated an "overweight" rating and set a $392.00 target price on shares of HCA Healthcare in a research report on Tuesday, October 1st. StockNews.com cut HCA Healthcare from a "strong-buy" rating to a "buy" rating in a research report on Monday, November 4th. Finally, Truist Financial increased their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a "buy" rating in a research report on Monday, August 19th. One analyst has rated the stock with a sell rating, five have assigned a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat, HCA Healthcare presently has a consensus rating of "Moderate Buy" and an average target price of $380.29.

Insider Activity at HCA Healthcare

In related news, SVP Phillip G. Billington sold 3,897 shares of the business's stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total transaction of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares in the company, valued at $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total value of $1,023,700.00. Following the sale, the insider now directly owns 6,843 shares of the company's stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 15,155 shares of company stock worth $5,608,990 in the last quarter. 1.70% of the stock is owned by company insiders.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.